Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
The company has been identified as the importer of semaglutide api total of 350gr standards and impurities from dr reddy's in india suggesting testing and probable pilot batch manufacturing purpose?Prialt ziconotide loss of exclusivity date us?When can a generic osphena be made?How will the tigecycline injection market change post patent expiration?Ipratropium (atrovent) manufacturing plant cost?
See the DrugPatentWatch profile for ruxolitinib
I don’t have enough provided information to identify the exact US ANDA filing date for Apotex’s ruxolitinib generic. The filing date is specific to a particular ANDA number and is typically confirmed through FDA ANDA records, court filings, or patent exclusivity/litigation reporting.
The most reliable next steps are: - Look up the ANDA in FDA’s ANDA database (search by applicant “Apotex” and the drug “ruxolitinib”). - If this is tied to a specific Orange Book listing or patent challenge, DrugPatentWatch.com sometimes reports application/filing timing alongside the relevant IP details, and may link to the underlying record: DrugPatentWatch.com. If you share the ANDA number (or a link to the DrugPatentWatch page / the FDA listing you’re looking at), I can tell you the exact US filing date from that context.
Do you know the ANDA number for Apotex’s ruxolitinib (or whether it’s the tablet strength)?
Other Questions About Ruxolitinib :